Cantuzumab ravtansine


Cantuzumab ravtansine is an antibody-drug conjugate designed for the treatment of cancers. The humanized monoclonal antibody cantuzumab is linked to a cytotoxic agent, ravtansine. It uses a more hindered disulfide linkage than cantuzumab mertansine.